These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 15248240)
1. Matrix metalloproteinase 9 in the saliva of patients with Sjögren's syndrome: comment on the article by Goicovich et al. Konttinen YT; Azuma M Arthritis Rheum; 2004 Jul; 50(7):2374; author reply 2375-6. PubMed ID: 15248240 [No Abstract] [Full Text] [Related]
2. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios. Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742 [TBL] [Abstract][Full Text] [Related]
3. Lysozyme determination in parotid saliva from patients with Sjögren's syndrome. Moutsopoulos HM; Karsh J; Wolf RO; Tarpley TM; Tylenda A; Papadopoulos NM Am J Med; 1980 Jul; 69(1):39-42. PubMed ID: 7386505 [TBL] [Abstract][Full Text] [Related]
4. Activation of MMP-9 activity by acrolein in saliva from patients with primary Sjögren's syndrome and its mechanism. Uemura T; Suzuki T; Saiki R; Dohmae N; Ito S; Takahashi H; Toida T; Kashiwagi K; Igarashi K Int J Biochem Cell Biol; 2017 Jul; 88():84-91. PubMed ID: 28483671 [TBL] [Abstract][Full Text] [Related]
13. [Hydrolases of the oral fluid in xerostomia]. Pozharitskaia MM; Vavilova TP; Fominova ZhN; Andreeva TB Stomatologiia (Mosk); 1982; (2):28-30. PubMed ID: 6283697 [No Abstract] [Full Text] [Related]
14. Error in Missing Journal Club Designation in: Sensitivity and Specificity of a Point-of-Care Matrix Metalloproteinase 9 Immunoassay for Diagnosing Inflammation Related to Dry Eye. JAMA Ophthalmol; 2013 Mar; 131(3):364. PubMed ID: 23753781 [No Abstract] [Full Text] [Related]
15. Lack of H-ATPase in distal nephron causing hypokalaemic distal RTA in a patient with Sjögren's syndrome. Bastani B; Haragsim L; Gluck S; Siamopoulos KC Nephrol Dial Transplant; 1995; 10(6):908-9. PubMed ID: 7566631 [No Abstract] [Full Text] [Related]
16. Dehydroepiandrosterone versus placebo for Sjögren's syndrome: comment on the article by Pillemer et al. van Vollenhoven R Arthritis Rheum; 2005 Aug; 53(4):626. PubMed ID: 16082652 [No Abstract] [Full Text] [Related]
17. Chemokine receptor expression by peripheral blood B lymphocytes in patients with primary Sjögren's syndrome: comment on the article by Hansen et al. Perucha E; Reyes E; Prieto A; Alvarez de Mon M; Rodríguez A; Zea A Arthritis Rheum; 2006 May; 54(5):1707-8; author reply 1708. PubMed ID: 16646060 [No Abstract] [Full Text] [Related]
18. Pilot clinical trial of dehydroepiandrosterone for Sjögren's syndrome: comment on the article by Pillemer et al. Toivanen A Arthritis Rheum; 2005 Aug; 53(4):626-7. PubMed ID: 16082644 [No Abstract] [Full Text] [Related]
19. Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity. Bertorello R; Cordone MP; Contini P; Rossi P; Indiveri F; Puppo F; Cordone G Clin Exp Med; 2004 Dec; 4(3):148-51. PubMed ID: 15599664 [TBL] [Abstract][Full Text] [Related]
20. Urinary matrix metalloproteinase-9 and interleukin-6 and renal manifestations of primary Sjogren's syndrome. Pertovaara M; Hulkkonen J; Hurme M; Lehtimäki T; Pasternack A Rheumatology (Oxford); 2004 Jun; 43(6):807-8. PubMed ID: 15163834 [No Abstract] [Full Text] [Related] [Next] [New Search]